References

Ahern AL, Aveyard P, Boyland EJ, Halford JCG, Jebb SA. Inequalities in the uptake of weight management interventions in a pragmatic trial: an observational study in primary care. Br J Gen Pract. 2016; 66:(645)e258-263 https://doi.org/10.3399/bjgp16X684337

All Wales Lymphoedema Obesity Policy Group. Lymphoedema management strategy for patients with a body mass index (BMI) equal to or greater than 30 kg/m2. 2014. https://tinyurl.com/yxh36rr9 (accessed 1 August 2019)

Tackling obesities: future choices—project report. 2007. https://tinyurl.com/ydd2r6ht (accessed 1 August 2019)

Clinical Resource Efficiency Support Team. Guidelines for the diagnosis, assessment and management of lymphoedema. 2008. https://tinyurl.com/y32pf5dq (accessed 1 August 2019)

Dalle Grave R, Calugi S, Molinari E QUOVADIS study group. Weight loss expectations in obese patients and treatment attrition: an observational multicenter study. Obes Res. 2005; 13:(11)1961-1969 https://doi.org/10.1038/oby.2005.241

Duyur Cakıt B, Pervane Vural S, Ayhan FF. Complex decongestive therapy in breast cancer-related lymphedema: does obesity affect the outcome negatively?. Lymphat Res Biol. 2019; 17:(1)45-50 https://doi.org/10.1089/lrb.2017.0086

Fife CE, Carter MJ. Lymphedema in the morbidly obese patient: unique challenges in a unique population. Ostomy Wound Manage. 2008; 54:(1)44-56

Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol. 1997; 65:(1)79-85

Fu M, Axelrod D, Guth A Patterns of obesity and lymph fluid level during the first year of breast cancer treatment: a prospective study. J Pers Med. 2015; 5:(3)326-340 https://doi.org/10.3390/jpm5030326

Jensen MD, Ryan DH, Apovian CM 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation. 2014; 129:S102-138 https://doi.org/10.1161/01.cir.0000437739.71477.ee

Jolly K, Daley A, Adab P, Denley J, Beach J, Aveyard P. A randomised controlled trial to compare a range of commercial or primary care led weight reduction programmes with a minimal intervention control for weight loss in obesity: the Lighten Up trial. BMC Public Health. 2010; 10 https://doi.org/10.1186/1471-2458-10-439

Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001; 27:363-385 https://doi.org/10.1146/annurev.soc.27.1.363

Lockwood K, Benson M, Cooke C. Obesity-related lymphoedema and hospice charities: considerations for the future. J Lymphoedema. 2017; 12:(1)46-48

London Cancer Alliance. Lymphoedema referral and management guidelines. 2015. https://tinyurl.com/yxjjqns6 (accessed 1 August 2019)

International Lymphoedema Framework. Best practice for the management of lymphoedema. 2006. https://tinyurl.com/y2dtxafk (accessed 21 July 2019)

Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link?. Plast Reconstr Surg. 2014; 134:(1)154e-160e https://doi.org/10.1097/PRS.0000000000000268

Owen-Smith A, Coast J, Donovan JL. Self-responsibility, rationing and treatment decision making—managing moral narratives alongside fiscal reality in the obesity surgery clinic. Health Expect. 2018; 21:606-614 https://doi.org/10.1111/hex.12651

Puhl R, Heuer CA. The stigma of obesity: a review and update. Obes Res. 2001; 9:(12)788-805

Sanchez-Ramirez DC, Long H, Mowat S, Hein C. Obesity education for front-line healthcare providers. BMC Med Educ. 2018; 18 https://doi.org/10.1186/s12909-018-1380-2

Scottish Government. A healthier future: Scotland's diet and healthy weight delivery plan. 2018. https://tinyurl.com/yyww9aen (accessed 21 July 2019)

Shallwani SM, Hodgson P, Towers A. Examining obesity in lymphedema: a retrospective study of 178 new patients with suspected lymphedema at a Canadian hospital-based clinic. Physiotherapy Canada. https://doi.org/10.3138/ptc-2018-0076

Shaw C, Mortimer P, Judd PA. A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer. 2007a; 110:(8)1868-1874 https://doi.org/10.1002/cncr.22994

Shaw C, Mortimer P, Judd PA. Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer. 2007b; 109:(10)1949-1956 https://doi.org/10.1002/cncr.22638

Spooner C, Upali WJ, Faruqi N, Stocks N, Harris MF. Predictors of weight stigma experienced by middle-older aged, general practice patients with obesity in disadvantages areas of Australia: a cross-sectional study. BMC Public Health. 2018; 18 https://doi.org/10.1186/s12889-018-5556-9

Todd M. Impact of multimorbidity on chronic oedema management in the older person. Br J Community Nurs. 2018a; 23:29-34 https://doi.org/10.12968/bjcn.2018.23.Sup10.S29

Todd M. Management of chronic oedema in patients with multiple morbidity. Br J Nurs. 2018b; 27:(4)186-188 https://doi.org/10.12968/bjon.2018.27.4.186

Wilkins C, Swain G, Cooke C. Facing up to the obesity crisis: outcomes of a bariatric lymphoedema clinic. J Lymphoedema. 2014; 9:(2)27-29

Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001; 21:(1)323-341 https://doi.org/10.1146/annurev.nutr.21.1.323

Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr. 2005; 82:222-225 https://doi.org/10.1093/ajcn/82.1.222S

World Health Organization. World health statistics 2018: monitoring health for the SDGs. 2018. https://tinyurl.com/y5sj3nml (accessed 26 July 2019)

Body weight and the management of lymphoedema

02 December 2019
Volume 24 · Issue 12

Abstract

Overweight and obesity are known risk factors for the development of lymphoedema, and are also well-recognised factors complicating the management of lymphoedema. However, a degree of uncertainty remains regarding the way in which obesity impacts upon the condition, and there is little detail about the practical application of weight management strategies in the population with lymphoedema. This article provides the background for ongoing research into the association between lymphoedema management and obesity. It is hoped that this research will provide important insights into the long-term management of lymphoedema.

The incidence and prevalence of overweight and obesity are increasing globally, with many developed nations struggling to reduce the rate. This, and the consequences of obesity, are often discussed in the literature at both the individual and population levels (Scottish Government, 2018; World Health Organization, 2018). Articles on lymphoedema are no different, with several published in the last year mentioning overweight and obesity as a risk factor for development of or a complicating factor in the management of the lymphoedema (Todd, 2018a; Duyur Cakit et al, 2019; Shallwani et al, 2019). Papers published in previous years highlight this point, while simultaneously describing an increased prevalence of overweight and obese individuals presenting in lymphoedema clinics and an additional level of complexity and treatment burden (from both the individual and service perspective) (Fife and Carter, 2008; Wilkins et al, 2014; Lockwood et al, 2017; Todd, 2018b). With this in mind, and an array of strategies, guidelines and management options, what should practitioners be recommending to clients? What should treatment goals look like? And what factors prevent or enable practitioners and patients in successfully incorporating weight within the lymphoedema assessment and management plan?

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month